Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020; 22(11):E911-918. doi:
10.1001/amajethics.2020.911.
A case that explores the impact of financial incentives from insurance companies on the patient-physician relationship and whether or not they should be disclosed to a patient.
Adrienne W. Henize, JD and Andrew F. Beck, MD, MPH
Data on certain chronic conditions’ prevalence, incidence of potentially preventable morbidity, and health-harming legal factors influence approaches to care.
AMA J Ethics. 2024; 26(8):E648-654. doi:
10.1001/amajethics.2024.648.
Professor Adrienne W. Henize joins Ethics Talk to discuss her article, coauthored with Dr Andrew F. Beck: “What Are Epidemiological Foundations for Integrating Legal Services Into Health Care Settings?”
Maeve Pascoe, MD, MS and Nancy Foldvary-Schaefer, DO, MS
Poor sleep affects nearly every organ system and influences many morbidity and mortality causes, so screening for sleep sufficiency and quality should be prioritized.
AMA J Ethics. 2024; 26(10):E749-754. doi:
10.1001/amajethics.2024.749.